Trials / Completed
CompletedNCT00000223
Alternate-Day Buprenorphine Administration. Phase IV - 5
Alternate-Day Buprenorphine Administration. Phase IV
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 20 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if three times a subject's daily maintenance dose will hold for 72 hours without changes in agonist and antagonist effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine |
Timeline
- Start date
- 1993-06-01
- First posted
- 1999-09-21
- Last updated
- 2005-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000223. Inclusion in this directory is not an endorsement.